Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis
Status:
Terminated
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The investigators are doing this research study to see if tocilizumab (Actemra) is safe and
effective when used for severe or refractory non-infectious uveitis. Uveitis is an
inflammation of the eye that is caused by the body's immune system reacting against the eye
tissues.